Equities

Narayana Hrudayalaya Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Narayana Hrudayalaya Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,829.10
  • Today's Change-2.10 / -0.11%
  • Shares traded154.90k
  • 1 Year change+37.01%
  • Beta0.7509
Data delayed at least 15 minutes, as of Feb 17 2026 10:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.

  • Revenue in INR (TTM)66.78bn
  • Net income in INR7.79bn
  • Incorporated2000
  • Employees11.41k
  • Location
    Narayana Hrudayalaya Ltd2nd Floor, No. 261/ABommasandra Industrial Area, Hosur RoadAnekal ThalukBANGALORE 560099IndiaIND
  • Phone+91 8 071222222
  • Fax+91 8 071222611
  • Websitehttps://www.narayanahealth.org/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Park Medi World Ltd15.73bn2.35bn75.89bn--32.06--24.824.835.485.4838.05------------------80.78--15.69----12.68----13.20--33.66------
Jupiter Life Line Hospitals Ltd14.38bn1.89bn80.78bn2.83k42.82--29.845.6228.7728.77219.33--------5,084,247.00--9.43--10.6281.0681.6013.1311.07--8.71--0.0017.9622.209.5645.5462.17--
Healthcare Global Enterprises Ltd24.72bn189.50m82.41bn5.83k436.39--31.103.331.341.34176.42--------4,239,393.00---0.6108---0.827851.1453.141.03-0.9047--1.13----16.2615.22-7.78--14.14--
Metropolis Healthcare Ltd15.66bn1.68bn100.43bn4.82k59.80--34.256.4132.4032.40301.90--------3,247,887.00--11.82--14.4578.4076.1410.8213.79--10.91--17.6310.239.2213.422.6313.64--
Vijaya Diagnostic Centre Ltd7.68bn1.59bn103.81bn2.22k65.05--42.1613.5215.5115.5174.73--------3,462,884.00--13.72--15.1288.0385.0920.8221.54--7.20--7.1924.3915.0020.4118.0014.98--
Rainbow Children's Medicare Ltd16.13bn2.58bn119.95bn3.97k46.65--29.717.4325.3325.33158.57--------4,061,639.00--10.64--11.6686.5483.5516.1115.21--9.43----16.8816.0812.1834.2914.35--
Dr. Agarwal's Health Care Ltd19.76bn1.26bn143.81bn3.37k114.41--34.237.283.973.9762.21--------5,862,326.00--------63.44--8.13----2.99----28.44--0.4804------
Dr. Lal PathLabs Ltd26.63bn5.28bn237.24bn4.98k44.84--34.548.9131.6831.68159.67--------5,346,978.00--15.99--20.0180.5876.8720.0216.80--28.16--17.4010.5413.0936.1716.61-7.5114.87
Krishna Institute Of Medical Sciencs Ltd36.27bn3.01bn273.86bn5.26k91.21--48.407.557.507.5090.50--------6,890,198.00--12.25--14.9979.5154.488.6815.55--3.61--0.0021.4922.0123.9726.4080.97--
Global Health Ltd41.82bn5.14bn307.62bn10.26k59.88--42.787.3619.1219.12155.68--------4,076,368.00--8.40--9.7676.9576.2312.2811.38--10.09----12.7419.730.678267.6728.04--
Aster DM Healthcare Ltd44.61bn3.27bn320.84bn15.29k96.89--51.267.196.416.4187.43--------2,917,520.00--2.22--3.7654.9958.298.054.98--3.66----11.88-13.71150.512.08-7.64--
Narayana Hrudayalaya Ltd66.78bn7.79bn373.07bn11.41k47.84--32.325.5938.4038.41329.60--------5,851,870.00--12.09--15.4264.7647.3511.6611.85--5.53--9.7712.1211.880.47346.0256.3335.10
Fortis Healthcare Ltd87.70bn9.60bn691.35bn12.24k72.02--49.017.8812.7212.72116.20--------7,167,094.00--4.60--5.8276.8272.8811.199.18--5.51--9.3912.9110.9329.2867.9540.28--
Data as of Feb 17 2026. Currency figures normalised to Narayana Hrudayalaya Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

9.83%Per cent of shares held by top holders
HolderShares% Held
Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 Jan 20265.14m2.51%
The Vanguard Group, Inc.as of 04 Feb 20262.64m1.29%
Templeton Asset Management Ltd.as of 31 Dec 20252.60m1.27%
PPFAS Asset Management Private Ltd.as of 31 Jan 20262.10m1.03%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 20251.99m0.97%
Axis Asset Management Co. Ltd.as of 31 Jan 20261.75m0.86%
BlackRock Fund Advisorsas of 06 Feb 20261.15m0.56%
Dimensional Fund Advisors LPas of 05 Feb 20261.11m0.54%
Norges Bank Investment Managementas of 30 Jun 2025886.19k0.43%
DSP Asset Managers Pvt. Ltd.as of 31 Jan 2026721.73k0.35%
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.